ESC 365 - Colchicine in acute coronary syndromes: a meta-analysis of 12.602 patients

ESC2025 Premium Access

Colchicine in acute coronary syndromes: a meta-analysis of 12.602 patients

Session: Pharmacotherapy in coronary artery disease (2)

Topic: Inflammation and Immunity

Speaker: Associate Professor G. Liuzzo (Rome, IT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Associate Professor Giovanna Liuzzo

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

4 presentations

0 follower

6 more presentations in this session

Combination therapy rapidly improves symptoms and quality of life in recently diagnosed angina patients: the COMBINE Angina study

Speaker: Professor M. Marzilli (Pisa, IT)

Efficacy and safety of selective serotonin reuptake inhibitors on cardiovascular outcomes of patients with post-acute coronary syndrome depression: a systematic review and meta-analysis

Speaker: Doctor J. Magno (Angeles City, PH)

Efficacy of PCSK9 inhibitors combined with statins versus statin monotherapy for secondary cardiovascular prevention: a systematic review and meta-analysis

Speaker: Mr M. Lang (Pilar, AR)

Association of colchicine with atrial fibrillation and safety outcomes in patients with acute coronary syndrome

Speaker: Doctor M. Tao (Hartford, US)

Safety and efficacy of edoxaban monotherapy vs dual antithrombotic therapy in patients with stable coronary artery disease and non-valvular atrial fibrillation: a systematic review and meta-analysis

Speaker: Doctor P. Go (Taguig, PH)

Access the full session

Pharmacotherapy in coronary artery disease (2)

Speakers: Associate Professor G. Liuzzo, Professor M. Marzilli, Doctor J. Magno, Mr M. Lang, Doctor M. Tao...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources